NAGIOS: RODERIC FUNCIONANDO

Efficacy of a mandibular advancement intraoral appliance (MOA) for the treatment of obstructive sleep apnea syndrome (OSAS) in pediatric patients : a pilot-study

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Efficacy of a mandibular advancement intraoral appliance (MOA) for the treatment of obstructive sleep apnea syndrome (OSAS) in pediatric patients : a pilot-study

Mostra el registre parcial de l'element

dc.contributor.author Modesti-Vedolin, Gabriela es
dc.contributor.author Chies, Caroline es
dc.contributor.author Chaves Fagondes, Simone es
dc.contributor.author Piza Pellizzer, Eduardo es
dc.contributor.author Grossi, Márcio L. es
dc.date.accessioned 2019-02-14T08:24:55Z
dc.date.available 2019-02-14T08:24:55Z
dc.date.issued 2018 es
dc.identifier.citation Modesti-Vedolin, Gabriela ; Chies, Caroline ; Chaves Fagondes, Simone ; Piza Pellizzer, Eduardo ; Grossi, Márcio L.. Efficacy of a mandibular advancement intraoral appliance (MOA) for the treatment of obstructive sleep apnea syndrome (OSAS) in pediatric patients : a pilot-study. En: Medicina oral, patología oral y cirugía bucal. Ed. inglesa, 23 6 2018: 4- es
dc.identifier.uri http://hdl.handle.net/10550/68962
dc.description.abstract To evaluate the treatment efficacy of a mandibular advancement intraoral appliance (MOA) for treatment of obstructive sleep apnea syndrome (OSAS) in pediatric patients. Eighteen patients (mean=8.39 years old, women=44.4%) were selected. Sleep disorders, sleep bruxism, and temporomandibular disorders were assessed by the Sleep Disturbance Scale for Children (SDSC), the BiteStrip® (portable SB device), and the Research Diagnostic Criteria for Temporomandibular Disorders, respectively. The clinical diagnosis of OSAS was confirmed with a type 3 portable monitor device (ApneaLinkTM Plus). A silicon-based material MOA was used by patients for 60 days, and the results were compared to baseline. The median RDI was significantly reduced from 10 to 4.5 events/hour. Nadir SpO2 significantly increased from 82.6% to 88.9%. Total snoring events/hour have also significantly decreased from 205.5 to 91.5. Signs and symptoms of TMD remained unaltered. There was also a reduction from moderate to absence of SB in 12 patients. Similarly, all variables measured by the SDSC have had very significant reductions: disorders of initiating and maintaining sleep, sleep disordered breathing, disorders of arousal, nightmares, sleep wake transition disorders, disorders of excessive somnolence, and sleep hyperhidrosis. In selected cases, OA maybe considered as an alternative for the OSAS treatment. es
dc.title Efficacy of a mandibular advancement intraoral appliance (MOA) for the treatment of obstructive sleep apnea syndrome (OSAS) in pediatric patients : a pilot-study es
dc.type journal article es_ES
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.identifier.doi 10.4317/medoral.22580 es
dc.type.hasVersion VoR es_ES

Visualització       (427.8Kb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques